RY

Rajyalakshmi Yarlagadda

Active Director Director DIN 07627086
DIN 07627086 First appointment Oct 2016 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2016
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajyalakshmi Yarlagadda

Data last updated:

Rajyalakshmi Yarlagadda is a Director at Alyosha Pharma Private Limited (since 2016). The company operates in Business Services.

DIN 07627086
Primary Designation Director
Industry Business Services
First Appointment 18 Oct 2016
Oldest Company Age 10 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Alyosha Pharma Private Limited U74999TG2016PTC112503
Director18 Oct 20162016Active

Board colleagues of Rajyalakshmi Yarlagadda

NameDINCompanyDesignation
Venkaiah Yarlagadda07627078Alyosha Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alyosha Pharma Private Limited
Premium access

Shareholding and investment profile for Rajyalakshmi Yarlagadda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajyalakshmi Yarlagadda

Rajyalakshmi Yarlagadda currently holds 1 directorship: Alyosha Pharma Private Limited (Director, since 18 Oct 2016).

Rajyalakshmi Yarlagadda was first appointed on 18 Oct 2016 as Director at Alyosha Pharma Private Limited.

The current boards of Rajyalakshmi Yarlagadda's companies include Venkaiah Yarlagadda (Alyosha Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available